Literature DB >> 26766585

Parsing Myc Paralogs in Oncogenesis.

Haritha Mathsyaraja1, Robert N Eisenman2.   

Abstract

Myc and its paralog MycN are thought to be functionally redundant, but Myc- and MycN-driven medulloblastomas exhibit distinct phenotypes. In this issue of Cancer Cell, Vo and colleagues (2016) show that this phenotypic difference stems from the preferential ability of Myc, relative to MycN, to bind Miz1 and repress transcription.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26766585     DOI: 10.1016/j.ccell.2015.12.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  7 in total

Review 1.  Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling.

Authors:  Olga Zaytseva; Leonie M Quinn
Journal:  Genes (Basel)       Date:  2017-04-11       Impact factor: 4.096

Review 2.  The MYCN Protein in Health and Disease.

Authors:  María Victoria Ruiz-Pérez; Aine Brigette Henley; Marie Arsenian-Henriksson
Journal:  Genes (Basel)       Date:  2017-03-30       Impact factor: 4.096

3.  Construction of a lncRNA-mediated feed-forward loop network reveals global topological features and prognostic motifs in human cancers.

Authors:  Shangwei Ning; Yue Gao; Peng Wang; Xiang Li; Hui Zhi; Yan Zhang; Yue Liu; Jizhou Zhang; Maoni Guo; Dong Han; Xia Li
Journal:  Oncotarget       Date:  2016-07-19

4.  MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma.

Authors:  Salvatore Raieli; Daniele Di Renzo; Silvia Lampis; Camilla Amadesi; Luca Montemurro; Andrea Pession; Patrizia Hrelia; Matthias Fischer; Roberto Tonelli
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

5.  Control Analysis of Protein-Protein Interaction Network Reveals Potential Regulatory Targets for MYCN.

Authors:  Chunyu Pan; Yuyan Zhu; Meng Yu; Yongkang Zhao; Changsheng Zhang; Xizhe Zhang; Yang Yao
Journal:  Front Oncol       Date:  2021-04-21       Impact factor: 6.244

6.  The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer.

Authors:  Xi-Xin Jin; Chao Gao; Wen-Xin Wei; Chong Jiao; Li Li; Bin-Lin Ma; Chao Dong
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy.

Authors:  Chantal Hoi Yin Cheung; Chia-Lang Hsu; Chao-Yin Tsuei; Tzu-Ting Kuo; Chen-Tsung Huang; Wen-Ming Hsu; Yun-Hsien Chung; Hsin-Yi Wu; Cheng-Chih Hsu; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Cell Death Dis       Date:  2019-10-17       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.